A tumor suppressor function of laminin-binding α-Dystroglycan

Methods in Enzymology

Volumn 479, Issue C, 2010, Pages 387-396

  Bao, Xingfeng ^a   Fukuda, Minoru ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; ALPHA DYSTROGLYCAN; LAMININ; PERLECAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASEMENT MEMBRANE; BINDING AFFINITY; BOOK; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION;

EID: 77956222787     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)79022-4     Document Type: Chapter

References (16)

1. Bao X., Kobayashi M., Hatakeyama S., Angata K., Gullberg D., Nakayama J., Fukuda M.N., Fukuda M. Tumor suppressor function of laminin-binding a-dystroglycan requires a distinct b3-N-acetylglucosaminyltransferase. Proc. Natl. Acad. Sci. USA 2009, 106:12109-12114.
2. Barresi R., Michele D.E., Kanagawa M., Harper H.A., Dovico S.A., Satz J.S., Moore S.A., Zhang W., Schachter H., Dumanski J.P., Cohn R.D., Nishino I., Campbell K.P. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat. Med. 2004, 10:696-703.
3. Barresi R., Campbell K.P. Dystroglycan: From biosynthesis to patjogenesis of human disease. J. Cell Sci. 2006, 119:199-207.
4. Bhowmick N.A., Neilson E.G., Morse H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
5. Chiba A., Matsumura K., Yamada H., Inazu T., Shimizu T., Kusunoki S., Kanazawa I., Kobata A., Endo T. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J. Biol. Chem. 1997, 272:2156-2162.
6. Jing J., Lien C.F., Sharma S., Rice J., Brennan P.A., Gorecki D.C. Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur. J. Cancer 2004, 40:2143-2151.
7. Larsen M., Artym V.V., Gree J.A., Yamada K.M. The matrix reorganized: Extracellular matrix remodeling and integrin signaling. Curr. Opin. Cell Biol. 2006, 18:463-471.
8. Martin P.T. Congenital muscular dystrophies involving the O-mannose pathway. Curr. Mol. Med. 2007, 7:417-425.
9. Muntoni F., Torelli S., Brockington M. Muscular dystrophies due to glycosylation defects in distinct congenital muscular dystrophies. Nat. Med. 2008, 10:696-703.
10. Muschler J., Levy D., Boudreau R., Henry M., Campbell K., Bissell M.J. A role for dystroglycan in epithelial polarization: Loss of function in breast tumor cells. Cancer Res. 2002, 62:7102-7109.
11. Sgambato A., de Paola B., Migaldi M., Di Salvatore M., Rettino A., Rossi G., Faraglia B., Boninsegna A., Mariorana A., Cittadini A. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J. Cell Physiol. 2007, 213:528-539.
12. Taddei I., Deugnier M.A., Faraldo M.A., Petit V., Bauvard D., Medina D., Fassler R., Thiery J.P., Glukhova M.A. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat. Cell Biol. 2008, 10:716-722.
13. Weiss L. Cancer cell heterogeneity. Cancer Metastasis Rev. 2000, 19:345-350.
14. White D.E., Kurpios N.A., Zuo D., Hassell J.A., Blaess S., Mueller U., Muller W.J. Targeted disruption of b1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cells 2004, 6:159-170.
15. Willer T., Prados B., Falcon-Perez J.M., Renner-Muller I., Przemeck G.K., Lommel M., Coloma A., Valero M.C., de Angelis M.H., Tanner W., Wolf E., Straul S., et al. Targeted disruption of the Walker-Warburg Syndrome gene Pomt1 in mouse results in embryonic lethality. Proc. Natl. Acad. Sci. USA 2004, 101:14126-14131.
16. Yoshida-Moriguchi T., Yu L., Stalnaker S.H., Davis S., Kunz S., Madson M., Oldstone M.B., Schachter H., Wells L., Campbell K.P. O-Mannosyl phosphoryaltion of alpha-dystroglycan is required for laminin-binding. Science 2010, 327:88-92.